Evidence map›Paper›PMID 42869589›Full record

ArticleBMJ open2026

Cohort profile: KaroLiver, a population-based cohort of patients receiving curative liver-directed treatment for colorectal liver metastases at a Swedish tertiary centre.

Marco Gerling, Carlos Fernández Moro, Celina Limbecker, Annika Viljamaa, Sara Harrizi, Yousra Hamidi, Ann-Kathrin Hailer, Johanna Sterner, Ernesto Sparrelid, Lorand Bozóky and 6 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in BMJ open, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Marco GerlingDepartment of Clinical Science, Intervention and Technology, Division of Surgery and Oncology, Karolinska Institutet, Stockholm, Sweden marco.gerling@ki.se.ORCID http://orcid.org/0000-0002-1810-0662
Carlos Fernández MoroDepartment of Laboratory Medicine, Division of Pathology, Karolinska Institutet, Stockholm, Sweden.
Celina LimbeckerDepartment of Clinical Science, Intervention and Technology, Division of Surgery and Oncology, Karolinska Institutet, Stockholm, Sweden.ORCID http://orcid.org/0009-0007-7262-4903
Annika ViljamaaDepartment of Clinical Science, Intervention and Technology, Division of Surgery and Oncology, Karolinska Institutet, Stockholm, Sweden.
Sara HarriziDepartment of Clinical Science, Intervention and Technology, Division of Surgery and Oncology, Karolinska Institutet, Stockholm, Sweden.
Yousra HamidiDepartment of Clinical Science, Intervention and Technology, Division of Surgery and Oncology, Karolinska Institutet, Stockholm, Sweden.
Ann-Kathrin HailerDepartment of Clinical Science, Intervention and Technology, Division of Surgery and Oncology, Karolinska Institutet, Stockholm, Sweden.
Johanna SternerDepartment of Clinical Science, Intervention and Technology, Division of Surgery and Oncology, Karolinska Institutet, Stockholm, Sweden.
Ernesto SparrelidDepartment of Clinical Science, Intervention and Technology, Division of Surgery and Oncology, Karolinska Institutet, Stockholm, Sweden.
Lorand BozókyDepartment of Clinical Science, Intervention and Technology, Division of Surgery and Oncology, Karolinska Institutet, Stockholm, Sweden.
Evelina Tidholm QvistDepartment of Clinical Pathology and Cancer Diagnostics, Karolinska University Hospital, Stockholm, Sweden.
Ruth BaumgartnerDepartment of Clinical Science, Intervention and Technology, Division of Surgery and Oncology, Karolinska Institutet, Stockholm, Sweden.ORCID http://orcid.org/0000-0001-6994-1421
Media Salmonson SchaadDepartment of Clinical Science, Intervention and Technology, Division of Surgery and Oncology, Karolinska Institutet, Stockholm, Sweden.
Béla BozókyDepartment of Clinical Pathology and Cancer Diagnostics, Karolinska University Hospital, Stockholm, Sweden.
Natalie GeyerDepartment of Clinical Science, Intervention and Technology, Division of Surgery and Oncology, Karolinska Institutet, Stockholm, Sweden.
Jennie EngstrandDepartment of Clinical Science, Intervention and Technology, Division of Surgery and Oncology, Karolinska Institutet, Stockholm, Sweden.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

CancerEuropeHepatobiliary surgeryHistopathologyLongitudinal studies

Identifiers

PMID42869589
PMCPMC13663752

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.